European Annals of Otorhinolaryngology-Head and Neck Diseases最新文献_第7页

Infraorbital hypoesthesia after diving 潜水后眶下感觉减退。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-05-01 DOI: 10.1016/j.anorl.2024.09.005

J.-B. Morvan , J.-B. Caruhel , M. Chery , V. Maso , A. Crambert

引用次数: 0

The effect of radiofrequency therapy for nasal valve collapse in endurance athletes: A STROBE analysis 射频治疗对耐力运动员鼻瓣膜塌陷的影响：一项频闪分析。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-05-01 DOI: 10.1016/j.anorl.2024.12.004

I.M.C. Seuthe , K. Van Ackeren , S. Dazert , S. Eichhorn , T. Veleva , J.J.-H. Park

{"title":"The effect of radiofrequency therapy for nasal valve collapse in endurance athletes: A STROBE analysis","authors":"I.M.C. Seuthe , K. Van Ackeren , S. Dazert , S. Eichhorn , T. Veleva , J.J.-H. Park","doi":"10.1016/j.anorl.2024.12.004","DOIUrl":"10.1016/j.anorl.2024.12.004","url":null,"abstract":"<div><h3>Objective</h3><div>Conducting a prospective pilot study to investigate the effect of temperature-controlled radiofrequency treatment of the nasal valve in endurance athletes with internal nasal valve collapse.</div></div><div><h3>Material and methods</h3><div>Twenty-five endurance athletes with nasal valve collapse were recruited from 2018 to 2020. Eight of the 25 patients dropped out of the study due to different reasons (injured due to non-nasal causes before postoperative measurement, refusal of surgery in the short term, termination due to corona pandemic), so that 17 study participants completed the study. We investigated NOSE questionnaire and rhinomanometry before and after radiofrequency treatment of the internal nasal valve (Vivaer radiofrequency probe). In addition, an exhaustive treadmill test before and after radiofrequency treatment was performed. The collected measurements were registered and compared with paired <em>t</em>-test. A Cohen's dz was performed for significant results. The normal distribution was confirmed by using the Kolmogorov-Smirnov test and Q-Q plots.</div></div><div><h3>Results</h3><div>There was a significant improvement in the NOSE score (<em>P</em>    <!-->1.03) and no serious side effects. No significant differences were seen before and after the treatment in rhinomanometry and spiroergometry.</div></div><div><h3>Conclusion</h3><div>Due to the low side effects and the subjective improvement in nasal breathing according to the NOSE score, the technique could perhaps represent a promising non-invasive therapy for improving nasal breathing in endurance athletes. However, no significant improvement was observed in the objective parameters. Larger study cohorts are required to investigate the effect in more detail.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"142 3","pages":"Pages 129-134"},"PeriodicalIF":1.9,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preoperative computed tomography imaging checklist for maxillary endoscopic prelacrimal approach. 上颌内窥镜泪前入路术前计算机断层成像检查表。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-04-24 DOI: 10.1016/j.anorl.2025.03.004

D Cunha-Cabral, P M Gomes, A A Carção, D Duarte, J F Penêda

引用次数: 0

Acute airway compromise in a patient with long-lasting dyspnea. 长期呼吸困难患者急性气道损害1例。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-04-24 DOI: 10.1016/j.anorl.2025.03.005

A D Asimakopoulos, S Yerly, S Bouayed

引用次数: 0

Improving the language environment for children with cochlear implants, using the LENA language and environment analysis system - A CONSORT analysis. 利用LENA语言与环境分析系统- A CONSORT分析，改善人工耳蜗植入儿童的语言环境。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-04-22 DOI: 10.1016/j.anorl.2025.04.004

M Lathuilliere, I Prang, M-C Picot, V Macioce, M Mondain, N Loundon

{"title":"Improving the language environment for children with cochlear implants, using the LENA language and environment analysis system - A CONSORT analysis.","authors":"M Lathuilliere, I Prang, M-C Picot, V Macioce, M Mondain, N Loundon","doi":"10.1016/j.anorl.2025.04.004","DOIUrl":"https://doi.org/10.1016/j.anorl.2025.04.004","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the contribution of family counseling based on Language and Environment Analysis (LENA) recording data to improving the language environment of children with cochlear implants.</p><p><strong>Material and methods: </strong>Cochlear implanted children with prelingual deafness were included from 2 French cochlear implant centers and randomized between 2 age-matched groups: intervention and control. LENA recording and lexical assessment (PPVT-R or GAEL-P) were performed at T1 and, 5 months later, T2. Between the two, intervention group families received feedback from the LENA recording and parental counseling.</p><p><strong>Endpoints: </strong>The main endpoint was improvement in language environment after LENA-based family counseling: adult word count (AWC), child vocalizations (CV), conversational turns (CT), and TV/media exposure (TV). Secondary endpoints comprised feasibility of LENA and the impact of the language environment on language reception (PPVT-R and GAEL-P scores).</p><p><strong>Results: </strong>Eighty-three of the 90 included children were analyzed. Mean age was 39±14.2 months, with 43 boys. Between T1 and T2, CT increased by 15 percentiles in the intervention group, in contrast to a median 0 change in controls (P=0.03). For the other 3 LENA parameters (CV, AWC, TV), median change was zero, in both groups. Mean implant acceptability rating was 83%. Lexical reception scores correlated positively with CV (r=0.37, P<0.01), AWC (r=0.31, P<0.01) and CT (r=0.41, P<0.01) but not with TV (r=0.11, P=0.33).</p><p><strong>Conclusion: </strong>The LENA system can help parents optimize the child's language environment, and thus oral language development, particularly in young children.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Predictive factors for postoperative outcome after endolymphatic sac surgery. Part 2: Quality of life. 内淋巴囊手术后预后的预测因素。第二部分：生活质量。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-04-16 DOI: 10.1016/j.anorl.2025.04.003

A Derieppe, K Bourget-Aguilar, P Bordure, G Michel

{"title":"Predictive factors for postoperative outcome after endolymphatic sac surgery. Part 2: Quality of life.","authors":"A Derieppe, K Bourget-Aguilar, P Bordure, G Michel","doi":"10.1016/j.anorl.2025.04.003","DOIUrl":"https://doi.org/10.1016/j.anorl.2025.04.003","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate improvement in quality of life (QoL) 2years after endolymphatic sac surgery (ESS) in patients with Ménière's disease (MD), and preoperative factors for QoL.</p><p><strong>Materials and methods: </strong>A retrospective single-center study included patients who underwent ESS between 2015 and 2022, with unilateral MD according to the criteria of the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) as revised in 2015, and resistant to first-line medical treatment. The main study endpoint was quality of life, measured on the MDOQ-R questionnaire.</p><p><strong>Results: </strong>Thirty-eight patients were included. Mean improvement in MDOQ-R score was 31.1±24.6 points [range: -29 to 79], and was significant (P<0.001). No predictive factors were identified.</p><p><strong>Conclusion: </strong>ESS provided significant and lasting improvement in quality of life. However, it was not possible to identify preoperative predictive factors for a \"typical\" patient profile with the highest likelihood of favorable outcome.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Predictive factors for postoperative outcome after endolymphatic sac surgery. Part 1: Clinical and prognostic STROBE report. 内淋巴囊手术后预后的预测因素。第一部分：临床和预后STROBE报告。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-04-16 DOI: 10.1016/j.anorl.2025.04.002

A Derieppe, K Bourget-Aguilar, P Bordure, G Michel

{"title":"Predictive factors for postoperative outcome after endolymphatic sac surgery. Part 1: Clinical and prognostic STROBE report.","authors":"A Derieppe, K Bourget-Aguilar, P Bordure, G Michel","doi":"10.1016/j.anorl.2025.04.002","DOIUrl":"https://doi.org/10.1016/j.anorl.2025.04.002","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate preoperative predictive factors 2years after endolymphatic sac surgery (ESS) in patients with Ménière's disease (MD).</p><p><strong>Materials and methods: </strong>A retrospective single-center study included patients who underwent ESS between 2015 and 2022, with unilateral MD according to the criteria of the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) as revised in 2015, and resistant to first-line medical treatment. The main study endpoint was the incidence of postoperative vertigo episodes. Secondary endpoints comprised hearing preservation at 2years and surgical efficacy.</p><p><strong>Results: </strong>Thirty-eight patients were included. Significant vertigo control was achieved in 63% (n=24). No predictive factors were identified for vertigo control or improvement in quality of life. Pure-tone and speech audiometric results were preserved at 2years. Whether the endolymphatic sac was sectioned or not did not significantly impact surgical outcome.</p><p><strong>Conclusion: </strong>No predictive factors for successful ESS emerged. ESS is a conservative second-line surgical treatment, with key indications for bilateral MD or MD in patients with preserved hearing.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144017552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose 贝伐珠单抗鼻喷雾剂治疗奥斯勒-韦伯-伦杜病鼻衄。EROSB研究：确定有效剂量。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-03-01 DOI: 10.1016/j.anorl.2024.10.006

L. Vincent , L. Robard , C. Creveuil , E. Babin , M. Perreard , M. Humbert

{"title":"Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose","authors":"L. Vincent , L. Robard , C. Creveuil , E. Babin , M. Perreard , M. Humbert","doi":"10.1016/j.anorl.2024.10.006","DOIUrl":"10.1016/j.anorl.2024.10.006","url":null,"abstract":"<div><div>Treatment of nosebleeds in Osler-Weber-Rendu disease (OWRD) is a therapeutic challenge. Intranasal anti-angiogenic sprays are a promising solution, requiring scientific validation, leading us to conduct the present study.</div></div><div><h3>Objective</h3><div>The main objective was to determine the minimum effective dose of bevacizumab by intranasal spray to treat epistaxis in OWRD: i.e., the dose resulting in≥50% reduction in the number of nosebleeds at 1 month of treatment compared to the month prior to inclusion for 60% of patients. The secondary objectives were to assess treatment efficacy at 3 and 6 months and progression in the number and impact of nosebleeds, and to document pharmacokinetics.</div></div><div><h3>Materials and methods</h3><div>The study, named EROSB (treatment of epistaxis in patients with OWRD using a bevacizumab intranasal spray), under the French Hospitals Clinical Research Program (PHRC-I 2013), was selected by the Inter-regional Clinical Research and Innovation Group (GIRCI). It was a phase I/II prospective single-blind study based on 10 cohorts of 3 patients each, using the Continual Reassessment Method (CRM) to determine the minimum effective dose of bevacizumab.</div></div><div><h3>Results</h3><div>Due to difficulties in recruiting enough patients, the study was stopped after inclusion of 15 subjects. The CRM method identified 64mg as the minimum effective dose. However, this result is not interpretable due to the small number of subjects.</div></div><div><h3>Conclusion</h3><div>The EROSB study did not succeed in identifying a minimum effective dose of bevacizumab, administered as intranasal spray that could reduce the number of nosebleeds compared to the month prior to inclusion. However, the initial results indicated almost no systemic passage of the substance.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"142 2","pages":"Pages 67-73"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Relevance of anatomical remnants for revision sinus surgery 解剖残留物与鼻窦翻修手术的相关性。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-03-01 DOI: 10.1016/j.anorl.2024.09.009

D. Martin-Jimenez , R. Moreno-Luna , C. Gago-Torres , J. Maza-Solano , S. Sanchez-Gomez

{"title":"Relevance of anatomical remnants for revision sinus surgery","authors":"D. Martin-Jimenez , R. Moreno-Luna , C. Gago-Torres , J. Maza-Solano , S. Sanchez-Gomez","doi":"10.1016/j.anorl.2024.09.009","DOIUrl":"10.1016/j.anorl.2024.09.009","url":null,"abstract":"<div><h3>Objectives</h3><div>Review of the scientific literature dedicated to investigating how residual structures impact surgical outcomes in chronic rhinosinusitis (CRS) patients, providing information on the frequency of anatomical remnants after endoscopic sinus surgery (ESS).</div></div><div><h3>Material and methods</h3><div>This review has been reported following the recommendations of the SWiM guideline. PubMed, Cochrane Library, Embase, and Web of Science were searched until April 2024. Studies selected for the systematic review were assessed about quality and risk of bias using the Oxford Centre for Evidence-Based Medicine Levels of Evidence and STROBE. The findings were analyzed descriptively and qualitatively, aligning with EPOS and ICAR guidelines.</div></div><div><h3>Results</h3><div>Fourteen relevant studies met the inclusion criteria for qualitative synthesis. Prospective and retrospective cross-sectional designs, focusing on revision ESS, were included. Four studies examined full-house functional ESS (FESS), three focused on frontal sinus surgery, four on conventional FESS and three did not specify the surgery type. The risk of bias was assessed, revealing significant variability in study quality and a low level of evidence. Wide variability was found in anatomical structures remaining after ESS, most notably in retained uncinate process (29.6–64%), agger nasi cell (4.5–83.33%) and frontoethmoidal cells (40.7–96.8%). Observations on concha bullosa, septal deviation and lateralization of the middle turbinate revealed distinct patterns among the included studies.</div></div><div><h3>Conclusion</h3><div>This systematic review underscores the persistent challenge of incomplete resection of anatomical structures in revision surgeries for CRS. The variability in the retention of key structures highlights the complexity of surgical outcomes and the need for further refinement in surgical techniques.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"142 2","pages":"Pages 84-92"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Laryngotracheal mucormycosis in children: Therapeutic challenges 儿童喉气管粘液瘤病：治疗难题。

IF 1.9 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-03-01 DOI: 10.1016/j.anorl.2024.10.005

É. Moreddu , M. Dallemagne , D. Rousseau , F. Blanc

引用次数: 0